(CDI) Christian Dior SE - Ratings and Ratios
Fashion, Leather, Wine, Spirits, Cosmetics
Dividends
| Dividend Yield | 3.23% |
| Yield on Cost 5y | 4.86% |
| Yield CAGR 5y | 29.66% |
| Payout Consistency | 94.3% |
| Payout Ratio | 51.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.5% |
| Value at Risk 5%th | 42.8% |
| Relative Tail Risk | -8.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.19 |
| Alpha | -1.69 |
| CAGR/Max DD | -0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.318 |
| Beta | 0.273 |
| Beta Downside | 0.341 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.27% |
| Mean DD | 22.23% |
| Median DD | 22.14% |
Description: CDI Christian Dior SE September 25, 2025
Christian Dior SE (ticker CDI) is a French luxury conglomerate that designs, manufactures, and sells fashion, leather goods, wines & spirits, perfumes & cosmetics, and watches & jewelry through a portfolio of globally recognized brands such as Louis Vuitton, Dior, Fendi, Hennessy, Moët & Chandon, Guerlain, Tiffany, and Bulgari.
The group reaches consumers via an extensive retail network-including flagship stores, the DFS Galleria, Sephora, and Le Bon Marché-as well as e-commerce platforms and a network of agents and distributors, giving it a multichannel presence that captured roughly 20% of total sales online in FY 2023.
In FY 2023 Dior reported revenue of €94 billion, with an operating margin of about 27%, reflecting strong pricing power and a favorable mix toward high-margin accessories and spirits; the China-Asia market contributed roughly 30% of total revenue, making regional demand a key driver of earnings.
Key sector dynamics include a projected 10% CAGR for the global luxury market over the next five years, driven by rising affluent consumer spending and digitalisation, while currency fluctuations (especially EUR/USD) remain a material risk to profitability.
For a deeper quantitative breakdown of Dior’s valuation multiples and scenario analysis, the ValueRay platform offers a useful toolkit.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (10.37b TTM) > 0 and > 6% of Revenue (6% = 10.10b TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA 8.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.68% (prev 7.81%; Δ 0.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.28 (>3.0%) and CFO 38.45b > Net Income 10.37b (YES >=105%, WARN >=100%) |
| Net Debt (30.89b) to EBITDA (48.25b) ratio: 0.64 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.48 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (180.4m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 67.30% (prev 68.65%; Δ -1.35pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 122.4% (prev 73.80%; Δ 48.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.67 (EBITDA TTM 48.25b / Interest Expense TTM 2.35b) >= 6 (WARN >= 3) |
Altman Z'' 3.79
| (A) 0.11 = (Total Current Assets 45.07b - Total Current Liabilities 30.45b) / Total Assets 138.72b |
| (B) 0.17 = Retained Earnings (Balance) 22.98b / Total Assets 138.72b |
| (C) 0.28 = EBIT TTM 39.10b / Avg Total Assets 137.62b |
| (D) 0.62 = Book Value of Equity 45.89b / Total Liabilities 74.30b |
| Total Rating: 3.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.87
| 1. Piotroski 7.0pt |
| 2. FCF Yield 19.10% |
| 3. FCF Margin 15.93% |
| 4. Debt/Equity 1.66 |
| 5. Debt/Ebitda 0.64 |
| 6. ROIC - WACC (= 53.30)% |
| 7. RoE 44.87% |
| 8. Rev. Trend 61.26% |
| 9. EPS Trend -3.05% |
What is the price of CDI shares?
Over the past week, the price has changed by +1.46%, over one month by +2.88%, over three months by +21.05% and over the past year by +9.74%.
Is CDI a buy, sell or hold?
What are the forecasts/targets for the CDI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 396 | -32.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 610.2 | 3.5% |
CDI Fundamental Data Overview November 27, 2025
Market Cap EUR = 104.46b (104.46b EUR * 1.0 EUR.EUR)
P/E Trailing = 22.9125
P/S = 1.2613
P/B = 4.4332
Beta = 1.026
Revenue TTM = 168.41b EUR
EBIT TTM = 39.10b EUR
EBITDA TTM = 48.25b EUR
Long Term Debt = 12.45b EUR (from longTermDebt, last quarter)
Short Term Debt = 12.60b EUR (from shortTermDebt, last quarter)
Debt = 39.18b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.89b EUR (from netDebt column, last quarter)
Enterprise Value = 140.49b EUR (104.46b + Debt 39.18b - CCE 3.15b)
Interest Coverage Ratio = 16.67 (Ebit TTM 39.10b / Interest Expense TTM 2.35b)
FCF Yield = 19.10% (FCF TTM 26.83b / Enterprise Value 140.49b)
FCF Margin = 15.93% (FCF TTM 26.83b / Revenue TTM 168.41b)
Net Margin = 6.16% (Net Income TTM 10.37b / Revenue TTM 168.41b)
Gross Margin = 67.30% ((Revenue TTM 168.41b - Cost of Revenue TTM 55.07b) / Revenue TTM)
Gross Margin QoQ = 66.84% (prev 65.27%)
Tobins Q-Ratio = 1.01 (Enterprise Value 140.49b / Total Assets 138.72b)
Interest Expense / Debt = 1.51% (Interest Expense 590.0m / Debt 39.18b)
Taxrate = 31.31% (2.68b / 8.57b)
NOPAT = 26.86b (EBIT 39.10b * (1 - 31.31%))
Current Ratio = 1.48 (Total Current Assets 45.07b / Total Current Liabilities 30.45b)
Debt / Equity = 1.66 (Debt 39.18b / totalStockholderEquity, last quarter 23.58b)
Debt / EBITDA = 0.64 (Net Debt 30.89b / EBITDA 48.25b)
Debt / FCF = 1.15 (Net Debt 30.89b / FCF TTM 26.83b)
Total Stockholder Equity = 23.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.48% (Net Income 10.37b / Total Assets 138.72b)
RoE = 44.87% (Net Income TTM 10.37b / Total Stockholder Equity 23.11b)
RoCE = 109.9% (EBIT 39.10b / Capital Employed (Equity 23.11b + L.T.Debt 12.45b))
RoIC = 58.69% (NOPAT 26.86b / Invested Capital 45.76b)
WACC = 5.39% (E(104.46b)/V(143.63b) * Re(7.02%) + D(39.18b)/V(143.63b) * Rd(1.51%) * (1-Tc(0.31)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.98% ; FCFE base≈21.78b ; Y1≈21.33b ; Y5≈21.71b
Fair Price DCF = 2137 (DCF Value 385.59b / Shares Outstanding 180.4m; 5y FCF grow -3.04% → 3.0% )
EPS Correlation: -3.05 | EPS CAGR: -45.76% | SUE: 0.0 | # QB: 0
Revenue Correlation: 61.26 | Revenue CAGR: 14.88% | SUE: N/A | # QB: 0